Thomas K. Equels
2012
In 2012, Thomas K. Equels earned a total compensation of $2.2M as General Counsel and Chief Financial Officer at Hemispherx Biopharma, a 159% increase compared to previous year.
Compensation breakdown
| Bonus | $1,288,693 |
|---|---|
| Option Awards | $87,246 |
| Salary | $694,068 |
| Other | $101,450 |
| Total | $2,171,457 |
Equels received $1.3M in bonus, accounting for 59% of the total pay in 2012.
Equels also received $87.2K in option awards, $694.1K in salary and $101.5K in other compensation.
Rankings
In 2012, Thomas K. Equels' compensation ranked 3,285th out of 11,487 executives tracked by ExecPay. In other words, Equels earned more than 71.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,285 out of 11,487 | 71st |
Division Manufacturing | 1,135 out of 4,253 | 73rd |
Major group Chemicals And Allied Products | 254 out of 1,203 | 79th |
Industry group Drugs | 149 out of 925 | 84th |
Industry Biological Products, Except Diagnostic Substances | 27 out of 165 | 84th |
Source: SEC filing on August 10, 2015.
Equels' colleagues
We found four more compensation records of executives who worked with Thomas K. Equels at Hemispherx Biopharma in 2012.